BrainStorm Announces Positive Trials of Its ALS Drug NurOwn

BrainStorm Cell Therapeutics, an Israeli developer of adult stem cell technologies for neurodegenerative diseases, announced that the Data and Safety Monitoring Board (DSMB) met to conduct its first safety More...